Endothelial NMMHC IIA Dissociation From PAR1 Activates the CREB3/ARF4 Signaling in Thrombin-Mediated Intracerebral Hemorrhage
November 2024
in “
Journal of Advanced Research
”
TLDR Targeting NMMHC IIA may help treat blood-brain barrier damage.
The study found that the dissociation of NMMHC IIA from PAR1 activates the CREB3/ARF4 signaling pathway, which exacerbates blood-brain barrier (BBB) damage caused by thrombin. This discovery suggests that NMMHC IIA could be a new therapeutic target for treating diseases related to BBB damage.